Global Urology Surgical Instruments Market Size Report Segmented by Product Type (Endoscopes, Endovision Systems, Consumables & Accessories), Application (Chronic Kidney Disease, Benign Prostatic Hyperplasia, Urinary Stones), End-user & Forecast to 2030

Overview

Urology surgical instruments refer to the specialised tools and devices used by medical professionals to diagnose, treat, and manage disorders related to the urinary tract and reproductive organs. These instruments are essential in a wide range of urological procedures, from minimally invasive diagnostics to complex surgeries, ensuring precision, patient safety, and improved outcomes. The advancement of urological instruments has significantly enhanced surgical efficiency, reduced recovery times, and enabled more effective disease management.

To learn more about this report, download the PDF brochure

Enhancing urological care through robotics and advanced imaging

One of the notable innovations in urological instruments market is the increasing use of robotic-assisted surgical systems. These systems allow for minimally invasive procedures with enhanced dexterity, 3D visualization, and reduced trauma to surrounding tissues, in complex procedures like prostatectomies and kidney surgeries, thereby offering benefits including reduced postoperative complications and faster recovery times.

The integration of high-definition imaging and advancements in digital endoscopy systems has significantly improved the visualization of anatomical structures. These modern endoscopes, equipped with high-resolution camera heads capable of delivering ultra-clear images, enable surgeons to perform procedures with greater efficiency and accuracy. Additionally, smart surgical instruments are also embedded with sensors and trackers that allow for real-time feedback and improved surgical planning. Overall, these technologies have improved patient care, expanded the scope of urological procedures and will continue to fuel consistent market growth.

Rising adoption of single-use surgical instruments for enhanced safety in urology care

Recently, there has been a shift from reusable to single-use, disposable instruments in urological surgery. These instruments prevent cross-contamination and reduce the risk of infections, which is a critical concern in surgical procedures. Disposable urology surgical instruments eliminate the need for sterilization and reprocessing, which helps healthcare providers ensure safer and more efficient patient care. Single-use urology instruments, including catheters, guidewires, dilators, and biopsy devices, are increasingly preferred in ambulatory care centres and hospitals. They help in minimizing procedure time and support faster patient turnover, which is especially important in high-volume environments. Furthermore, the growing focus on infection control and hospital-acquired infection (HAI) prevention has supported the shift towards disposable instruments. The rising demand for cost-effective surgical solutions is also driving hospitals and surgical centers to adopt disposable instruments, as they help avoid the long-term costs associated with instrument maintenance, sterilization, and replacement.

To learn more about this report, download the PDF brochure

Recent developments in the urology surgical instruments market

Recent developments in the urology surgical instruments market reflect ongoing innovation and regulatory progress across imaging, robotics, and single-use technologies. Some recent FDA approvals and launch of advanced solutions aimed at enhancing surgical precision, reducing infection risk, and improving patient outcomes are listed below:

• In June 2025, Ambu received FDA clearance for the aScope 5 Cysto HD, a single-use flexible cysto-nephroscope approved for percutaneous nephrolithotomy (PCNL) in the US
• In September 2024, Olympus Corporation launched its CHS70008LB 4K camera head designed for urological endoscopy. The device provides ultra-high resolution and enhanced visualization through Narrow Band Imaging (NBI), enabling better diagnosis and precision in bladder and ureteral procedures
• In June 2024, Intuitive Surgical received FDA clearance for an updated labelling of its da Vinci X and Xi robotic systems, officially recognizing radical prostatectomy as a supported procedure based on real-world evidence showing comparable 5-10 year overall survival to non-robotic surgery
• In April 2024, Olympus received FDA clearance for RenaFlex, its first single-use flexible ureteroscope. The device offers features including ergonomic design and high-resolution imaging to support stone management and improve urologic care
• In April 2023, Intuitive Surgical received FDA clearance for the da Vinci SP (Single Port) system to perform simple and transvesical prostatectomy procedures. This expanded the urology indications for da Vinci SP, recognizing its specialized, minimally invasive one-port capabilities for prostate surgeries
• In February 2023, Boston Scientific received FDA clearance for the LithoVueElite system, a single-use digital flexible ureteroscope equipped with a real-time intrarenal pressure sensor, delivering precise imaging while reducing cross-contamination risks

Competitive Landscape Analysis

The global urology surgical instruments market comprises several well-established and emerging players, including Medtronic plc; Boston Scientific Corporation; Olympus Corporation; Karl Storz SE & Co. KG; Cook Medical LLC; Richard Wolf GmbH; Stryker Corporation; Teleflex Incorporated; Coloplast Group; and Becton, Dickinson and Company among others. These companies are engaged in the development, manufacturing, and distribution of a wide range of surgical instruments used in urology, such as endoscopes, catheters, dilators, resectoscopes, and robotic-assisted devices. Their key strategies include continuous investment in R&D, expansion of product portfolios, development of advanced technologies, and strategic collaborations with healthcare providers to meet the increasing demand for minimally invasive and precision-driven urological procedures worldwide.

Report Scope

Global Urology Surgical Instruments Market Segmentation

This report by Medi-Tech Insights provides the size of the global urology surgical instruments market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product type, application, and end-user.

Market Size & Forecast (2023-2030), By Product Type, USD Million

• Endoscopes
• Endovision Systems
• Peripheral Systems
• Consumables & Accessories
• Others

Market Size & Forecast (2023-2030), By Application, USD Million

• Chronic Kidney Disease (CKD)
• Benign Prostatic Hyperplasia (BPH)
• Urinary Stones
• Pelvic Organ Prolapse (POP)
• Oncology
• Other

Market Size & Forecast (2023-2030), By End-user, USD Million

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Other

Market Size & Forecast (2023-2030), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Key Strategic Questions Addressed

• What is the market size & forecast of the urology surgical instruments market?
• What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the urology surgical instruments market?
• What are the key trends defining the market?
• What are the major factors impacting the market?
• What are the opportunities prevailing in the market?
• Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
• Who are the major players operating in the market?
• What are the key strategies adopted by players?